SCN1A and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy: Our genetic testing showed that 1 of 3 (33.3%) patients with clinically Dravet syndrome and 3 of 20 (15%) patients diagnosed as GEFS+, had SCN1A mutation.